Autoantibodies against neuropeptides are associated with psychological traits in eating disorders.
Previously, we identified that a majority of patients with anorexia nervosa (AN) and bulimia nervosa (BN) as well as some control subjects display autoantibodies (autoAbs) reacting with alpha-melanocyte-stimulating hormone (alpha-MSH) or adrenocorticotropic hormone, melanocortin peptides involved in appetite control and the stress response. In this work, we studied the relevance of such autoAbs to AN and BN. In addition to previously identified neuropeptide autoAbs, the current study revealed the presence of autoAbs reacting with oxytocin (OT) or vasopressin (VP) in both patients and controls. Analysis of serum levels of identified autoAbs showed an increase of IgM autoAbs against alpha-MSH, OT, and VP as well as of IgG autoAbs against VP in AN patients when compared with BN patients and controls. Further, we investigated whether levels of these autoAbs correlated with psychological traits characteristic for eating disorders. We found significantly altered correlations between alpha-MSH autoAb levels and the total Eating Disorder Inventory-2 score, as well as most of its subscale dimensions in AN and BN patients vs. controls. Remarkably, these correlations were opposite in AN vs. BN patients. In contrast, levels of autoAbs reacting with adrenocorticotropic hormone, OT, or VP had only few altered correlations with the Eating Disorder Inventory-2 subscale dimensions in AN and BN patients. Thus, our data reveal that core psychobehavioral abnormalities characteristic for eating disorders correlate with the levels of autoAbs against alpha-MSH, suggesting that AN and BN may be associated with autoAb-mediated dysfunctions of primarily the melanocortin system.
Fetissov
Sergueï O
SO
Department of Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden. serguei.fetissov@univ-rouen.fr
Harro
Jaanus
J
Jaanisk
Maiken
M
Järv
Anu
A
Podar
Iris
I
Allik
Jüri
J
Nilsson
Ida
I
Sakthivel
Priya
P
Lefvert
Ann Kari
AK
Hökfelt
Tomas
T
D000328:Adult; D000704:Analysis of Variance; D000856:Anorexia Nervosa / Q000276:immunology* / Q000523:psychology; D001323:Autoantibodies / Q000097:blood* / Q000276:immunology; D001526:Behavioral Symptoms; D052018:Bulimia Nervosa / Q000276:immunology* / Q000523:psychology; D004797:Enzyme-Linked Immunosorbent Assay; D004957:Estonia; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D009074:Melanocyte-Stimulating Hormones; D009479:Neuropeptides / Q000276:immunology*; D010098:Oxycodone; D014667:Vasopressins
D001323:Autoantibodies; D009479:Neuropeptides; D014667:Vasopressins; D009074:Melanocyte-Stimulating Hormones; D010098:Oxycodone